127 related articles for article (PubMed ID: 8574606)
1. Drug administration in critically ill patients with acute renal failure.
Kroh UF
New Horiz; 1995 Nov; 3(4):748-59. PubMed ID: 8574606
[TBL] [Abstract][Full Text] [Related]
2. [Drugs in the intensive care unit--need for dosage adjustment in organ failure].
Kroh UF; Lennartz H
Klin Wochenschr; 1991; 69 Suppl 26():24-31. PubMed ID: 1813726
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
4. Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units.
Brause M; Neumann A; Schumacher T; Grabensee B; Heering P
Crit Care Med; 2003 Mar; 31(3):841-6. PubMed ID: 12626994
[TBL] [Abstract][Full Text] [Related]
5. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
6. [Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
Kroh U; Hofmann W; Dehne M; el Abed K; Lennartz H
Anaesthesist; 1989 May; 38(5):225-32. PubMed ID: 2660626
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].
Morabito S; Guzzo I; Vitaliano E; Muzi L; Solazzo A; Pistolesi V; Pierucci A
G Ital Nefrol; 2006; 23 Suppl 36():S127-38. PubMed ID: 17068740
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
Heintz BH; Matzke GR; Dager WE
Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
[TBL] [Abstract][Full Text] [Related]
9. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.
van der Voort PH; Boerma EC; Koopmans M; Zandberg M; de Ruiter J; Gerritsen RT; Egbers PH; Kingma WP; Kuiper MA
Crit Care Med; 2009 Feb; 37(2):533-8. PubMed ID: 19114909
[TBL] [Abstract][Full Text] [Related]
10. [Infection-induced change in the pharmacokinetics of cefotaxime. Dose calculation in multiple organ failure and relevance of score systems].
Hofmann W; Kroh U; Lennartz H
Klin Wochenschr; 1991; 69 Suppl 26():32-5. PubMed ID: 1813727
[TBL] [Abstract][Full Text] [Related]
11. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.
Eachempati SR; Wang JC; Hydo LJ; Shou J; Barie PS
J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940
[TBL] [Abstract][Full Text] [Related]
12. The impact of continuous renal replacement therapy on drug therapy.
Susla GM
Clin Pharmacol Ther; 2009 Nov; 86(5):562-5. PubMed ID: 19727069
[TBL] [Abstract][Full Text] [Related]
13. Drug dosing in continuous renal replacement therapy: general rules.
Schetz M
Curr Opin Crit Care; 2007 Dec; 13(6):645-51. PubMed ID: 17975384
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
[TBL] [Abstract][Full Text] [Related]
15. [Adjusting dosage of drugs in patients with kidney or liver failure].
Krähenbühl S
Schweiz Med Wochenschr; 1998 Feb; 128(6):189-94. PubMed ID: 9540139
[TBL] [Abstract][Full Text] [Related]
16. Drug dosing during continuous arteriovenous hemofiltration.
Bickley SK
Clin Pharm; 1988 Mar; 7(3):198-206. PubMed ID: 3281789
[TBL] [Abstract][Full Text] [Related]
17. Principles of antibacterial dosing in continuous renal replacement therapy.
Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
[TBL] [Abstract][Full Text] [Related]
18. Continuous renal replacement therapy in critically ill patients.
Zobel G; Rödl S; Urlesberger B; Kuttnig-Haim M; Ring E
Kidney Int Suppl; 1998 May; 66():S169-73. PubMed ID: 9573597
[TBL] [Abstract][Full Text] [Related]
19. Drug removal in continuous haemofiltration and haemodialysis.
Davies JG; Kingswood JC; Sharpstone P; Street MK
Br J Hosp Med; 1995 Nov 15-Dec 12; 54(10):524-8. PubMed ID: 8574497
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of continuous veno-venous haemofiltration in critically ill patients.
Sorkine P; Halpern P; Scarlat A; Weinbroum A; Silbiger A; Setton A; Rudick V
Clin Intensive Care; 1994; 5(6):293-5. PubMed ID: 10150557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
